Mind Medicine (MindMed) (MMEDF) News Today $7.56 +0.47 (+6.63%) (As of 11/22/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period MindMed call volume above normal and directionally bullishNovember 23 at 10:56 PM | markets.businessinsider.comRBC Capital Remains a Buy on Mind Medicine (MNMD)November 21 at 8:25 PM | markets.businessinsider.comMind Medicine price target raised to $16 from $14 at CanaccordNovember 9, 2024 | markets.businessinsider.comMind Medicine: A Strong Buy on Financial Health and Growth ProspectsOctober 12, 2024 | markets.businessinsider.comMind Medicine (MindMed) Inc. (MNMD) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | seekingalpha.comPsychedelics Company MindMed Prices Public Offering Aiming To Raise $75MAugust 12, 2024 | msn.comPsychedelic Medicine Has a Therapy ProblemAugust 12, 2024 | msn.comMind Medicine Shares Drop 12% After Public Offering PricesAugust 9, 2024 | marketwatch.comBuy Rating Affirmed for Mind Medicine on Impressive MM120 Developments and Phase 3 Trial ProspectsJuly 31, 2024 | markets.businessinsider.comMind Medicine (MindMed) Inc. (MNMD)April 17, 2024 | finance.yahoo.comMind Medicine (NASDAQ:MNMD) is Leading the Surge in Psychedelic TherapiesMarch 27, 2024 | msn.comMind Medicine Inc Ordinary SharesMarch 22, 2024 | morningstar.comMind Medicine Inc Ordinary Shares MMEDMarch 17, 2024 | morningstar.comMind Medicine Stock (NASDAQ:MNMD) Dividends: History, Yield and DatesFebruary 22, 2024 | benzinga.comMMDCF Mind Medicine (MindMed) Inc. WT EXP 010724December 20, 2023 | seekingalpha.comWhat Makes Mind Medicine (MindMed) Inc. (MNMD) a New Buy StockDecember 20, 2023 | msn.comMind Medicine (MindMed) Inc. (MMCWF)December 12, 2023 | finance.yahoo.comMindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business UpdateOctober 26, 2023 | financialpost.comMindMed Inks $50M Credit Facility Deal With K2 HealthVentures For An Additional Operational YearAugust 15, 2023 | benzinga.comRBC Capital Maintains Mind Medicine (MNMD) Outperform RecommendationAugust 4, 2023 | msn.comThinking about buying stock in Mind Medicine (MindMed), OPKO Health, Grange Resources, Hyzon Motors, or Bright Minds Biosciences?July 19, 2023 | stockhouse.comMind Medicine (MindMed), Inc.July 4, 2023 | thestreet.comMindMed Shareholders Vote For All Six Company Nominees At Annual Meeting, Current R&D Path UpheldJune 27, 2023 | msn.com8-K: Mind Medicine (MindMed) Inc.June 22, 2023 | marketwatch.comMindMed Releases Investor Presentation Highlighting How the Company is Unlocking the Power of Psychedelics for Patients and ShareholdersMay 25, 2023 | businesswire.comFCM Releases Letter to Fellow MindMed Shareholders Highlighting Board and Management's Track Record of Shareholder Value DestructionMay 5, 2023 | benzinga.comMindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business UpdateMay 1, 2023 | benzinga.comMindMed CEO On Latest Positive Topline Phase 2 Data And Freedom Capital ManagementApril 26, 2023 | msn.comMindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 TrialsNovember 11, 2022 | benzinga.comMind Medicine (MNMD) to Report Q3 Earnings: What's in Store?October 26, 2022 | msn.comWhy Mind Medicine Stock Triumphed on TuesdayOctober 4, 2022 | nasdaq.comWhy Mind Medicine Stock Soared on a Down Day for the MarketSeptember 29, 2022 | nasdaq.comMind Medicine Inc (MNMD)September 29, 2022 | uk.investing.comMind Medicine Stock (NASDAQ:MNMD): Investors Just Got a Dose of RealitySeptember 28, 2022 | nasdaq.comStock of psychedelics company MindMed slides 50% after it sells fresh sharesSeptember 28, 2022 | msn.comWhy MindMed Stock Is Tanking TodaySeptember 28, 2022 | msn.comMindMed Announces Proposed Public Offering of Common SharesSeptember 27, 2022 | benzinga.comMindMed to Participate in H.C. Wainwright Global Investment ConferenceSeptember 15, 2022 | finance.yahoo.comMind Medicine shares up as Phase 2b studies continue on medical LSDSeptember 9, 2022 | msn.comWhy Mind Medicine (MindMed) Stock Tumbled This WeekSeptember 8, 2022 | msn.comMindMed: Confusing MEME Rally Hides A Company That Looks Empty Of ValueSeptember 4, 2022 | seekingalpha.comWall Street Analysts Predict a 399% Upside in Mind Medicine MindMed Inc. (MNMD): Here's What You Should KnowAugust 30, 2022 | finance.yahoo.comWhy Mind Medicine Stock Crushed the Market on FridayAugust 12, 2022 | nasdaq.comMindMed Announces At-The-Market OfferingMay 16, 2022 | finance.yahoo.comMind Medicine Q1 Earnings PreviewMay 13, 2022 | seekingalpha.comMindMed stock rises as phase 2 study shows benefit of LSD in anxiety disordersMay 11, 2022 | seekingalpha.comMind Medicine: It's Best To Stay Far Away From This Risky Psychedelic StockApril 21, 2022 | seekingalpha.comMindMed Engages in Productive Pre-Submission Meeting with FDA for Development of the MindMed Session Monitoring SystemDecember 9, 2021 | prnewswire.comPsyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize PsychedelicsSeptember 14, 2021 | benzinga.comImon Ghosh - Page 9September 10, 2021 | entrepreneur.com Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MMEDF and its competitors with MarketBeat's FREE daily newsletter. Email Address Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. MMEDF Media Mentions By Week MMEDF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MMEDF News Sentiment▼0.000.49▲Average Medical News Sentiment MMEDF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MMEDF Articles This Week▼20▲MMEDF Articles Average Week Get Mind Medicine (MindMed) News Delivered to You Automatically Sign up to receive the latest news and ratings for MMEDF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Today Algernon Pharmaceuticals News Today Allstar Health Brands News Today Alvotech News Today American Premium Mining News Today Anew Medical News Today Arno Therapeutics News Today AstraZeneca News Today AVVAA World Health Care Products News Today Basilea Pharmaceutica News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MMEDF) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mind Medicine (MindMed) Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mind Medicine (MindMed) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MMEDF Stock Alerts